CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$0.58
+0.01 (+1.27%)
Open$0.57
Previous Close$0.58
Day High$0.61
Day Low$0.56
52W High$3.62
52W Low$0.56
Volume—
Avg Volume4.12M
Market Cap58.06M
P/E Ratio—
EPS$-0.42
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+3,959.7% upside
Current
$0.58
$0.58
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.12M | 24.12M | 28.34M |
| Net Income | 5.84M | 5.30M | 5.57M |
| Profit Margin | 21.6% | 22.0% | 19.7% |
| EBITDA | 7.13M | 6.78M | 8.30M |
| Free Cash Flow | 3.88M | 4.04M | 6.28M |
| Rev Growth | -4.2% | +22.6% | +13.0% |
| Debt/Equity | 1.37 | 0.99 | 1.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |